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Purpose: The purpose of this study was to evaluate ndovascular stenting (EVS) and 
balloon fenestration (BF) of intimal flaps for the management of lower extremity, renal, 
and visceral ischemia in acute or chronic aortic dissection. 
Methods: Twenty-two patients (16 male, 6 female) with a median age of 53 years (range 
35 to 77 years) underwent percutaneous treatment for peripheral ischemic omplications 
of 12 type A (five acute, seven chronic) and 10 type B (nine acute, one chronic) aortic 
dissections. 
Results: Ten patients had leg ischemia, 13 had renal ischemia, and 6 had visceral ischemia. 
Sixteen patients were treated with EVS including 11 with renal, 6 with lower extremity, 
2 with superior mesenteric artery, and 2 with aortic stents. Three patients had BF of the 
intimal flap, and three had BF in combination with EVS. Revascularization with clinical 
success was achieved in all 22 patients. Two patients died 3 days and 13.4 months after 
the procedure was performed, respectively. Of the remaining 20 patients, 1 is lost to 
follow-up, and 19 have persistent relief of clinical symptoms. Mean follow-up time is 13.7 
months (range 1.1 to 46.5 months). One case was complicated by guidewire-induced 
perinephric hematoma. 
Conclusion: EVS and BF provide a safe and effective percutaneous method for managing 
peripheral ischemic omplications of aortic dissection. (J VASC SURG 1996;23:241-53.) 
Aortic dissection is complicated by peripheral 
vascular ischemic symptoms in approximately 30% of 
patients.l-4 Most of these ischemic omplications will 
be relieved by standard surgical treatment of the 
dissection. 4'5 In patients who do not undergo surgical 
treatment of the dissection or in patients who have 
persistent peripheral vascular ischemia after under- 
going thoracic aortic operation, the appropriate 
management of these complications has yet to be well 
established. This issue is of critical importance 
because a high mortality rate occurs in patients with 
dissections complicated by ischemia involving the 
renal, mesenteric, and lower extremity vasculature 
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whether or not they undergo surgical treatment. 2-4,6 
We report he use of endovascular stents and balloon 
fenestration in the percutaneous management of 
ischemic omplications of aortic dissection. 
MATERIAL  AND METHODS 
Patients. From August 1991 through April 
1995, 22 patients (16 men and 6 women) underwent 
endovascular stenting, balloon fenestration, or both 
of an intimal flap causing renal, mesenteric, or lower 
extremity ischemia. Four of these 22 patients (7, 9, 
11, 22) were included in a previous report. 7 The 
median age of the patients was 53 years, with a range 
of 35 to 77 years. Eighteen of the patients had a 
history of hypertension. Two of the patients had 
Marfan Syndrome. 
Twelve patients had a Stanford type A dissection. 
The dissection was acute (less than 14 days between 
the onset of symptoms and the ndovascular p oce- 
dure) in five patients and chronic in seven. All five 
patients with an acute dissection tmderwent surgical 
repair of the ascending aorta before undergoing the 
endovascular p ocedure. In four of these five patients 
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the endovascular p ocedure was performed within 24 
hours of the operation, and in the fifth patient it was 
performed 10 days after the operation. Six of the 
seven patients with a chronic dissection underwent 
surgical repair of the ascending aorta before under- 
going the endovascular p ocedure. The endovascular 
procedure was performed between 1day and 6 years 
(median 2 months) after the operation. One patient 
with a chronic dissection had no surgical treatment. 
Ten patients had Stanford type B dissections, of 
which nine were acute and one was chronic. Six of 
the patients with an acute dissection had not un- 
dergone an aortic operation before undergoing the 
endovascular procedure. Two patients had previ- 
ously undergone surgical repair of a type A dis- 
section 2 and 8 years before undergoing the en- 
dovascular procedure, respectively. One patient had 
graft replacement of the descending thoracic aorta 
before undergoing the endovascular procedure on 
the same day. The patient with the chronic dis- 
section had no operation. 
Patients were referred for angiographic evalua- 
tion and possible ndovascular treatment of ischemic 
complications because of clinical suspicion of com- 
promise of one or more abdominal aortic branches by 
the dissection process. Clinical signs or symptoms of 
lower extremity ischemia included an absent or 
decreased pulse, pain, coolness, altered sensation, or 
claudication. Renal ischemia was indicated by wors- 
ening hypertension or hypertension resistant to 
medical therapy, elevated serum creatinine, oliguria, 
or anuria. Mesenteric ischemia was suspected in the 
presence of abdominal pain, nausea and vomiting, 
abnormal iver function tests, or acidosis. Any of 
these signs or symptoms in patients who had no 
imaging evidence of compromised arterial supply to 
the suspected ischemic region by spiral computed 
tomography, arteriography, or intravascular ultra- 
sonography (IVUS) were not attributed to ischemia 
or to the dissection process. 
Procedure. All endovascular procedures were 
performed in the angiography suite. Arterial access 
was gained through the common femoral artery, the 
brachial artery, or both for initial arteriographic 
evaluation. When the false lumen was patent, images 
were obtained after sequential selective catheteriza- 
tion of both the truc and false lumens was performed. 
If access into both the true and false lumen could not 
be achieved via a single puncture site, another access 
site was used. In patients with signs of renal 
insufficiency, portions of the procedure were per- 
formed with hand-injected carbon dioxide as the 
contrast agent in association with digital subtraction 
arteriography tominimize the volume ofnephrotoxic 
iodinated contrast media used. s
Stenting. Stenting was performed with balloon- 
expandable Palmaz stents (Johnson and Johnson 
Interventional Systems, Warren, N.J.) (15 patients), 
self-expanding Wallstents (Schneider, Plymouth, 
Minn.) (2 patients), or both (2 patients). In the 
aortic branch vessels Palmaz stents were deployed 
on 6 to 12 mm balloon catheters requiring 7F to 
9F angiographic sheaths. Alternatively, 10 to 12 
mm diameter self-expanding Wallstents requiring a 
7F angiographic sheath for introduction were de- 
ployed. In the aorta, balloon-expandable Palmaz 
stents were deployed on 18 to 25 mm balloon 
catheters (Mansfield, Watertown, Mass.) requiring 
9F to 14F angiographic sheaths. 
Balloon fenestration. Fenestrations were per- 
formed with either IVUS or fluoroscopic guidance. 
With either technique percutaneous catheterization 
of both the true and false lumen was initially 
performed. When IVUS guidance was used (Fig. 1), 
an 8F IVUS probe (Cardiovascular Imaging Sys- 
tems, Sunnyvale, Calif.) was placed through an 8F 
angiographic sheath into the larger (usually false) 
lumen while a long, curved, metallic Rosch-Uchida 
carmula (Cook, Bloomington, In&) or a Colapinto 
needle (Cook) was placed through a 7F sheath into 
the other lumen. The cannula or needle was posi- 
tioned at the same level as the IVUS probe to allow 
real-time guidance during creation of the fenestra- 
tion. A small needle (0.038 inches) was passed 
through the Rosch-Uchida cannula, or a guidewire 
(0.035 inches) was passed through the Colapinto 
needle through the intimal flap into the opposite 
lumen. The IVUS was continuously monitored to 
ensure that the puncture would be made through the 
middle of the intimal flap and not toward a free wall 
of the aorta. A 5F angiographic catheter was then 
advanced over the needle or guidewire across the flap, 
and a hand injection of contrast media was used to 
confirm its position in the opposite lumen. The 
angiographic atheter was removed, and a balloon 
catheter was advanced over a guidewire to dilate the 
fenestration i the intimal flap. 
When fluoroscopic guidance was used, a balloon 
catheter was placed in the larger lumen and used as a 
target, with the caimula or needle in the smaller 
lumen. The tip of the cannula or needle was pointed 
toward the inflated balloon. The alignment of the 
cannula or needle and the balloon was confirmed 
with multiple fluoroscopic obliquities to ensure that 
the puncture would be made through the intimal flap 
into or toward the balloon rather than toward a free 
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Fig. 1. A, Arteriogram demonstrates noflow into left common lilac artery in this patient with 
chronic type A dissection (case 10). B, Fluoroscopic image depicts 8F intravascular 
ultrasonography (IVUS) probe extending up true lumen of right external lilac artery, across 
reentry tear at level of internal lilac artery, into false lumen in aorta. A 7F Rosch-Uchida cannula 
loaded with small needle is in true lumen of left lilac artery. C, Needle is passed through intimal 
flap into opposite lumen u der IVUS guidance. D, A 5F angiographic catheter is advanced over 
needle into opposite lumen. Needle is withdrawn, and guidewire is advanced into opposite 
lumen. 
wall of the aorta. Otherwise, the technique was the 
same as with IVUS guidance. In one patient the 
smaller lumen was believed to be too compressed to 
allow safe passage of the needle from the groin to the 
planned level of the fenestration. In this case the 
inflated balloon was placed in the smaller lumen to 
expand it while the needle was passed through the 
intimal flap via the other lumen. 
RESULTS 
With the lower extremities, the kidneys, and the 
mesenteric vasculature each considered as one vascu- 
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Fig. 1. E, Balloon catheter is advanced over guidewire todilate fenestration i intimal flap. F, 
Arteriogram demonstrates flow in left iliac artery after stenting of chronic dissection. 
lar bed, 16 patients had involvement of only one 
vascular bed, 5 patients had involvement of two 
vascular beds, and 1 patient had involvement of all 
three at initial presentation. The distribution of vessel 
involvement is summarized in Table I. Thirteen 
patients had renal ischemia. Of  these, eight had 
unilateral (two right and six left) and five had bilateral 
involvement. Ten patients had lower extremity isch- 
emia, including nine with unilateral (seven right and 
two left) and one with bilateral involvement. Six 
patients had mesenteric ischemia. 
Sixteen patients were treated with endovascular 
stents, three with balloon fenestration of the intimal 
flap, and three with fenestration i combination with 
stenting of the aorta or its branches. The specifica- 
tions of these endovascular t eatments are detailed in 
Table II. 
Stents. Thirteen patients were treated with renal 
stents (Fig. 2). Of  these, 11 had unilateral (three right 
and eight left) and 2 had bilateral stents placed. Eight 
patients were treated with lower extremity stents, 
seven with unilateral (five fight and two left) and one 
with bilateral stents. Two patients were treated with 
aortic stents, and two were treated with superior 
mesenteric artery stents. Of  the 16 patients treated 
with stents alone, 7 patients had stenting only of 
renal, 2 only of lower extremity, and 2 only of 
mesenteric arteries. Three had stenting of renal and 
lower extremity arteries. One had stenting of lower 
extremity arteries and the aorta (Fig. 3). 
Fenestration. Of  the three patients treated with 
balloon fenestration of the intimal flap, two had the 
fenestration performed in the distal thoracic aorta 
and dilated to 14 mm diameter. In one patient the 
fenestration was performed in the distal abdominal 
aorta and dilated to 12 mm. 
Fenestration and stent. Of  the three patients 
treated with a combination of balloon fenestration 
and stenting, the fenestration was performed in the 
distal thoracic aorta in one patient (12 mm diameter) 
and in the distal abdominal aorta in two patients (10 
mm and 12 mm diameter). One patient had stents 
placed in a lower extremity artery and both renal 
arteries. One patient had a stent placed only in an iliac 
artery, extending through the fenestration. One 
patient had a stent placed in a renal artery. 
Outcomes. Revascularization with initial clinical 
success was achieved in all 22 patients. One patient 
died of peritonitis three days after undergoing the 
procedure. The peritonitis was likely related to 
prolonged bowel ischemia (30-day mortality rate, 
4.5%). One patient died of cardiorespiratory arrest 
13.4 months after undergoing the procedure; how- 
ever, he had persistent relief of clinical symptoms 
related to the treated vascular beds until the time of 
death. One patient is lost to follow-up but had no 
symptoms at the time of discharge from the hospital. 
One patient in whom a renal artery stent was 
placed had a perinephric hematoma. This complica- 
tion was believed to be due to penetration of a branch 
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Table I. Clinical characteristics of 22 patients with aortic dissection complicated by peripheral 
vascular ischemia who were treated with endovascular techniques 
[schemia 
Renal Leg 
No. ~ Sex Age (yr) Type Duration Right Left Right Left Mesenteric 
1 M 37 
2 M 44 
3 M 49 
4 M 52 
5 F 75 
6 M 35 
7 M 44 
8 M 44 
9 M 54 
10 M 58 
11 M 59 
12A M 77 
12B M 77 
13 " M 39 
14 M 42 
15A M 47 
15B M 47 
16 F 49 
17A F 53 
17B F 53 
18 F 57 
19 M 57 
20 M 59 
21 F 62 
22 F 66 
A Acute 
A Acute 
A Acute 
A Acute 
A Acute 
A Chronic 
A Chronic 
A Chronic 
A Chronic 
A Chronic 
A Chroxfic 
A Chronic 
A Chronic 
B Acute 
B Acute 
B Acute 
B Chronic 
B Acute 
B Acute 
B Acute 
B Acute 
B Acute 
B Acute 
B Acute 
B Chronic 
M, Male; F, female. 
SAn "A" notation in the No. column indicates the first of two presentations of the same patient, and a "B" notation indicates the second. 
vessel of the renal artery by the guidewire while the 
stent was being deployed. The patient required 
transfusion of 3 U of blood and percntaneous 
embolization ofthe small bleeding branch artery with 
coils. No long-term sequelae of the complication 
have been seen. 
Three patients had recurrence ofacute symptoms 
and had additional endovascular procedures per- 
formed. One patient (case 12) with renal and lower 
extremity ischemia who was initially treated with 
stenting of the aorta and left renal artery returned 2 
months after the initial procedure with hypertension 
and disabling claudication. Further stenting of the 
aorta and the right renal artery was performed. The 
patient remains free of symptoms with good medical 
blood pressure control at 1 month after the repeat 
procedure. 
One patient (case 15) initially had an acute 
Stanford type B dissection with thrombosis of the 
false lumen and the left renal artery, which it 
supplied. The celiac axis, superior mesenteric artery, 
inferior mesenteric artery, and right renal artery 
originated from the true lumen. A flap extending into 
the right renal artery was treated with a right renal 
artery stent. The patient was seen again 6 weeks later 
with new symptoms of renal, mesenteric, and lower 
extremity ischemia and paraplegia. Computed to- 
mography examination identified a new enhancing 
crescentic hannel within the false lumen with 
interval displacement of thrombus causing oblitera- 
tion of the true lumen to a paper-thin sliver. He was 
transferred to our institution with a profound meta- 
boric acidosis and anuria for 15 hours. At this point 
the true lumen of the aorta was stented from just 
distal to the left subclavian artery to the infrarenal 
abdominal aorta. In spite of initial clinical improve- 
ment, he had gastrointestinal bleeding, which was 
thought o be due to ischemia. Arteriography per- 
formed 11 days after stenting of the aorta demon- 
strated the celiac axis, superior mesenteric artery, and 
inferior mesenteric artery to be patent. At exploratory 
laparotomy he was found to have ischemic sigmoid 
colon, for which he received a left hemicolectomy. 
This patient remains hospitalized with complications 
from his colon operation 1.5 months after his repeat 
endovascular p ocedure. Although his serum creati- 
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Table II. Specifications of end•vascular treatments in 22 patients with aortic dissection including 
locations of stents and fenestrations, tent types, and fenestration diameters 
Stent location Stent ype Fenestration 
Renal Leg 
No. ~ Right Left Right Left SAgA Aorta Palmaz Wallstent Location Diameur(mm) 
1 • • 
2 • • 
3 • • • 
4 • • • 
5 • • 
6 • • 
7 • • 
8 
9 • • 
10 • 
11 
12A 
12B 
13 
14 
15A 
15B 
16 
17A 
• Distal thoracic aorta 14 
• Distal abdominal 10 
aorta 
• Distal thoracic aorta 14 
• • 
• • • • 
• • • Distal abdominal 12 
aorta 
1713 • • • • • 
18 • • • • 
19 • • • 
20 • • 
21 
22 • • • • 
• Distal abdominal 12 
aorta 
• Distal thoracic aorta 12 
SMA, Superior mesenteric artery. 
SAn "A" notation i  the No. column indicates the first of two presentations f the same patient, and a "B" notation i dicates the second. 
nine initially rose to 7.7, his renal function has 
returned to normal, with a creatinine of 1.5. 
One patient (case 17) was treated initially with a 
balloon fenestration i  the distal aorta and stenting of 
the left renal artery. After having initial improve- 
ment, she had deterioration i  right ankle/brachial 
index measurements caused by intermittent obstruc- 
tion of  the right iliac artery orifice by a mobile 
segment of the distal aortic intimal flap just below the 
fenestration. She was brought back during the same 
hospitalization 6 days after the initial procedure and 
had stents placed in both iliac arteries and the distal 
aorta. She remains without symptoms 7 months after 
undergoing her repeat end•vascular p ocedure. 
One patient (case 8) with prolonged mesenteric 
ischemia who was treated with fenestration alone 
initially had symptomatic relief and col•nose•pie 
evidence of  healing ischemia. He had persistent food 
intolerance and weight loss caused by ischemic 
strictures of his pylorus and small bowel, These 
injuries were believed to be due to the long interval 
of significant ischemia existing before end•vascular 
therapy. 
The remaining patients have persistent relief of 
clinical symptoms. No patient has required surgical 
revascularization f  the ischemic region. No patient 
has had chronic renal failure. Mean follow-up time is 
13.7 months (range 1.1 to 46.5 months, median 7.5 
months). 
D ISCUSSION 
The management of peripheral vascular ischemic 
complications of aortic dissection is a challenging 
problem with important implications because of the 
increased mortality of patients with renal, mesenteric, 
or lower extremity ischemia. Although surgical repair 
of the dissected aorta usually relieves the peripheral 
ischemic symptoms, in some cases ischemia persists. 
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Fig. 2. A, Selective left renal arteriogram (case 12) demonstrates irregular intimal contour at 
orifice of renal artery (arrow). B, Image from IVUS study of left renal artery demonstrates 
dissection flap (straight arrow), with true lumen (curved arrow) compressed by false lumen. C, 
Palmaz stent is deployed in proximal renal rtery with angioplasty balloon. D, Arteriogram 
performed after deployment of stent reveals widely patent left renal artery. 
Patients who do not undergo surgical repair of the 
dissection may require treatment for the peripheral 
ischemia. Historically, surgical procedures including 
graft revascularization of the affected aortic branch 
vessel or fenestration of the intimal flap have been the 
only therapeutic alternatives. These surgical proce- 
dures in patients who are often medically unstable 
because of the dissection or the peripheral ischemia 
can have high complication and mortality rates. 3
Several animal and cadaver studies have been 
performed to evaluate the potential for primary 
treatment of the dissected aorta with endovascular 
covered or uncovered stents or balloon fenestration 
of the intimal flap. 9-18 These studies have not 
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Fig. 3. A, Arteriogram with injection of contrast media into true lumen of abdominal orta 
demonstrates it to be severely compressed (case 17). Celiac xis, superior mesenteric artery 
(cumed arrow), two left renal arteries (straight arrows), and both iliac arteries are supplied by true 
lumen. Flow to iliac arteries i  significantly compromised. B, After deployment ofaortic Palmaz 
stents, flow to right iliac artery remains impaired. C, Restoration of normal flow is seen after 
additional stents are deployed in iliac arteries. 
specifically addressed peripheral vascular ischemic 
complications of the dissection process. Isolated cases 
of the use of percutaneous procedures including 
balloon angioplasty, endovascular stenting, and bal- 
loon fenestration of the intimal flap to manage 
ischemic complications rclated to aortic dissection 
have been reported. 7'~924 
Our experience with 22 patients treated percuta- 
neously for peripheral ischemic complications of  
aortic dissection includes cases that required stenting, 
JOURNAL OF VASCULAR SURGERY 
Volume 23, Number 2 Slonim et aL 249 
balloon fenestration, or a combination of both 
procedures. Because of the extreme complexity of 
aortic dissection, it is difficult o establish astandard- 
ized endovascular pproach to its management. As 
the dissection extends distally, propagation of the flap 
follows an unpredictable idiosyncratic course. Each 
patient has a unique array of signs and symptoms. 
The interventional approach to each patient is 
tailored to the clinical signs, symptoms, and the 
specific anatomic ondition and hemodynamics of
the dissection. 
In general, however, it is possible to divide the 
peripheral ischemic omplications ofaortic dissection 
into two pathophysiologic groups. In the first group 
the ischemia is due to a primary peripheral problem, 
with extension of the dissection flap into the aortic 
branch vessel. If no distal branch vessel reentry of the 
dissection is present, the true lumen is usually 
compressed, causing impaired perfusion to the vas- 
cular bed. Most of these cases require stenting of the 
true lumen with compression of the false lumen to 
restore adequate flow. In cases in which reentry of the 
dissection is present, theoretically the vascular bed is 
supplied by both the true and false lumens. These 
patients may not have clinical symptoms and may 
require no intervention. Alternatively, the modified 
hemodynamics aused by the presence of a flap may 
cause ischemia. In this setting stenting is also the 
endovascular treatment of choice. Therefore if isch- 
emia is caused by a primary peripheral problem of the 
aortic branch vessel, stenting of the branch vessel true 
lumen is usually required. 
In the second pathophysiologic group the isch- 
emia is due to a global problem within the aorta. The 
ischemia is caused by encroachment on the aortic 
lumen that provides the primary blood supply to a 
branch vessel, with a significant pressure gradient 
between the lumens. The terms "true lumen" and 
"false lumen" are intentionally omitted from this 
discussion because the primary blood supply to an 
aortic branch vessel after a dissection may be from any 
lumen. The objective in endovascular therapy is to 
restore adequate perfusion to the vascular bed 
regardless of the lumen from which it originates. If 
the lumen providing the primary blood supply is 
compressed by another lumen that has flow, balloon 
fenestration of the intimal flap will allow better 
admixture of the flow between the two lumens, with 
equalization of pressure gradients and relief of 
compression. Fenestration may have to be performed 
at multiple levels within the aorta. 
Another treatment option for this group is the 
deployment of aortic stents within the lumen sup- 
plying the branch vessel to hold the lumen open. 
With this technique the stent displaces the intimal 
flap toward the other lumen and mechanically 
overcomes the pressure gradient. The other lumen 
usually cannot be completely obliterated by stenting. 
In the acute setting as the dissection occurs, the 
diameter of the vessel increases because the blood 
flow through the false lumen stretches the adventitia. 
The intima will not stretch to the same dimension to 
allow successful reapproximation f the flap to the 
outer wall. In a chronic dissection the intimal flap 
usually thickens and contracts as it heals, making it 
less pliable and more resistant o being stretched. 
Also, obliteration of the false lumen is not necessarily 
a reasonable goal, because it may provide the only 
blood supply to multiple vascular beds. 
If the ischemia is due to compression of the 
supplying aortic lumen by thrombosis of another 
lumen, the supplying lumen must be stented. In the 
setting of partial thrombosis fenestration carries the 
risk of allowing distal embolization. 
If the ischemia is due to thrombosis of the aortic 
lumen providing the primary blood supply to a 
branch vessel, the intervention of choice depends on 
clinical considerations. Usually the branch vessel of 
interest has undergone thrombosis as well. If the 
vascular bed can be sacrificed (for example, a renal 
artery in a patient with a functioning second kidney), 
no intervention may be undertaken. In a setting 
where reestablishment of flow is crucial, surgical 
revascularization may be an option. These patients 
are often poor surgical candidates, however, because 
of their severe clinical conditions. As an alternative 
thrombolysis could be considered, although it has 
never been performed at our institution in the setting 
of an aortic dissection. 
The evaluation of the efficacy of endovascular 
techniques in relieving peripheral vascular ischemic 
symptoms in patients with aortic dissection can be 
very difficult. Lower extremity and mesenteric sch- 
emia can usually be attributed to the dissection on the 
basis of an angiogram. The presence of renal ischemia 
caused by an aortic dissection, however, can be 
particularly challenging to confirm. Most patients 
with an aortic dissection have preexisting hyperten- 
sion, making it difficult o attribute the hypertension 
to a dissection involving a renal artery. The renal 
artery involvement may contribute a reversible com- 
ponent o the hypertension, however, making it more 
severe. Serum creatinine is also an unreliable indica- 
tor of renal ischemia caused by a dissection. Acute 
renal ischemia will not be manifested with an 
elevation of serum creatinine for several hours to 
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days. A patient with an aortic dissection may present 
with elevated serum creatinine on the basis of chronic 
renal insufficiency caused by hypertension or other 
medical conditions. Clinical signs or symptoms 
referable to a specific vascular bed are attributed to 
the dissection if imaging evidence that the supplying 
artery is altered by the dissection process is seen. The 
presence of both signs or symptoms and an abnormal 
arteriographic or IV-US appearance is considered an 
indication to attempt endovascular management. 
Resolution of signs and symptoms related to the 
treated vascular bed after an intervention is consid- 
ered success. Relief of lower extremity ischemia is 
usually apparent, with return of pulses, resolution of 
pain, etc. Patients with mesenteric ischemia may have 
objective vidence of restoration ofperfusion yet may 
continue to have symptoms related to sequelae of 
transient significant ischemia. If hypertension or 
elevated serum creatinine do not resolve after an 
intervention, it is impossible to establish whethcr the 
intervention was a failure or the patient was returned 
to a baseline state of blood pressure and renal 
function after successful treatment. Similar limita- 
tions apply to the evaluation of the efficacy of surgical 
revascularization. 
The results of these endovascular techniques in 
managing the peripheral vascular ischemic omplica- 
tions of aortic dissection are very promising. Clinical 
and imaging studies of their long-term effectiveness 
and durability have yet to be carried out. The surgical 
alternatives to these ndovascular p ocedures, which 
most often include isolated repair of the dissected 
thoracic aorta, surgical fenestration of the intimal 
flap, and direct revascularization with bypass graft- 
ing, have longer follow-up studies. 
Surgical repair of the dissected thoracic aorta 
resuks in resolution of peripheral pulse deficits in up 
to 92% of patients. 3'4 Patients with mesenteric and 
renal ischemia, however, have poorer outcomes, with 
operative mortality rates of 43% and 50%, respec- 
tively. 4 In those patients who require further treat- 
ment, surgical fenestration through aretroperitoneal 
approach can provide ffective reperfusion. 3,2a In one 
series of i4 patients 2s all survived the procedure, and 
13 had successful organ reperfusion (11 with lower 
extremity and 2 with renal ischemia). Of the 11 
patients surviving to discharge, none had further 
ischemic omplications related to the dissection, with 
a mean follow-up time of 5 years. 
Reports of direct revascularization with a bypass 
graft to treat ischemic omplications of dissection 
have involved smaller numbers of patients. One series 
reported two of eight patients with mesenteric 
ischemia or infarction treated with a bypass graft. 
Both of these patients' died of the ischemic injury in 
the perioperative p riod. 3In the same series 2 of 11 
patients with renal ischemia related to a dissection 
were treated with direct revascularization with a 
bypass graft. Although these patients urvived, renal 
function did not improve. Bypass grafting to revas- 
cularize ischemic lower extremities has favorable 
results; however, numbers are small (because symp- 
toms are usuallyrelieved bycentral aortic repair), and 
follow-up periods are not specified. 3'2s 
CONCLUSION 
Management of the peripheral vascular ischemic 
complications of aortic dissection is a complex and 
challenging problem, particularly because of the 
increased mortality rate of patients with renal, 
mesenteric, or lower extremity ischemia. Persistent 
ischemia fter surgical repair of the dissection or in 
patients who do not undergo surgical repair may be 
safely and effectively treated with the endovascular 
techniques of stenting and balloon fenestration. In
general, an aortic dissection can cause ischemia either 
by a primary peripheral or a global aortic problem. A
primary peripheral problem is caused by extension of 
the dissection i to a branch vessel, usually requiring 
endovascular stenting. A global aortic problem is 
caused by encroachment on the aortic lumen that 
provides the primary blood supply to a branch vessel. 
The endovascular management of these problems 
requires tenting, fenestration, or a combination of 
both. The approach to each patient must be uniquely 
formulated on the basis of clinical signs and symp- 
toms and on the anatomy and hemodynamics of the 
dissection. 
Although the long-term durability of endovascu- 
lar stenting and balloon fenestration have yet to be 
established, these techniques compare favorably with 
available surgical treatment options with regard to 
effectiveness of early revascularization. Although 
further studies are necessary before these procedures 
are widely adopted, they provide a promising treat- 
ment alternative in these patients with complications 
who are often undesirable surgical candidates. 
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D ISCUSSION 
Dr. Richard P. Cambria (Boston, Mass.). This report 
represents an updating of the Stanford experience with 
endovascular management of a spectrum of vascular 
complications resulting from spontaneous aortic dissection 
and is an extension of their original five patients presented 
before these Societies in 1992. 
Review of their manuscript indicates that these inter- 
ventions are hardly simple maneuvers, often requiring 
simultaneous access to both lumens of a dissected aorta, 
frequently from concomitant upper and lower extremity 
arterial access ites, and in many cases with in situ guidance 
with intravascular ultrasonography. Indeed, I suspect hat 
many of the skeptical vascular surgeons in the audience may 
have said of Dr. Slonim's first illustrated case, that a 
femorofemoral bypass would have been a lot simpler 
solution. 
Although the numbers are small and experience at any 
one institution is limited, this is an important report, 
because acute aortic dissection continues to be the most 
common aortic emergency treated at our institution. Based 
on our own data detailed before these Societies in 1987 and 
that from Stanford, approximately one third of patients 
with acute aortic dissection will have significant aortic 
branch compromise, which clearly increases the overall 
mortality. And in certain vascular beds, such as carotid, 
renal, and mesenteric, these vascular complications will 
dominate as the immediate cause of death. 
The management of these patients has remained 
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controversial, both with respect o the role of medical 
versus urgical therapy of distal dissections and the related 
issue of whether therapy should be directed at the site of the 
peripheral vascular complication or the proximal tear. 
Stated differently, how effective is proximal aortic opera- 
tion at relieving peripheral vascular complications? 
My own belief is that proximal operation will solve the 
problem only for certain of the different mechanisms of 
downstream obstruction. Over half of the patients in this 
report, 12 of 22, underwent a distal endovascular inter- 
vention within hours or days of surgery because of failure 
of proximal aortic operation to correct he distal vascular 
complication. If this happens rarely, as the groups from 
Stanford and Houston have previously stated, then directed 
peripheral operation or endovascular intervention should 
be required only rarely. This appears not to be the case 
based on what we heard this morning. 
My first question is, has the group at Stanford changed 
its position on the efficacy of proximal operation in treating 
peripheral vascular complication? I recognize that Dr. 
Slonim, as an interventional radiologist, may be ill- 
equipped to answer that question. 
The clinical profile of their patients is interesting. Only 
five of their patients were older than 60 years of age. The 
mean age of the remaining 17 was only 48 years. Thus it 
would appear that these interventions were not chosen 
because the patients were elderly or in ill health; rather, they 
seemed to be young patients in whom therapy with an 
expected urable result would be optimal. 
My second question is, were these interventional 
procedures chosen because the authors believed them to be 
less invasive or more effective than conventional vascular 
surgery operation or because so many of them occurred 
shortly after a proximal aortic operation? 
The authors conclude that endovascular stenting and 
balloon fenestration is safe and effective treatment for these 
problems, and Dr. Slonim has kindly updated me on the 
clinical status of one recently treated patient. Being the 
devil's advocate, one could assess that their results are 
perhaps not so good, with mortality being 2 of 22 patients, 
or 9%, and an unsatisfactory outcome as measured by a bad 
short-term result or the need for reintervention i 27% of 
their patients. Particularly notable was the poor outcome of 
three of six patients with mesenteric schemia. 
My third question is, based on what we have heard 
today and the poor results in the patients with mesenteric 
ischemia, would the Stanford group be prepared to change 
its position in patients who present with a mesenteric 
vascular complication or acute abdominal aortic occlusion 
of an acute dissection? 
These patients present complex problems and are a 
heterogeneous group. The necessity for proximal operation 
and the mechanism and significance of the peripheral 
vascular complication are the important factors in individu- 
alizing optimal management. The approach outlined today 
will be appropriate for some, but hardly all, of these 
complicated patients. 
Dr. Suzanne M. Slonim (Stanford, Calif.). The man- 
agement of aortic dissections at Stanford and the question 
of whether surgical attention should be directed first to the 
central aortic tear or to the peripheral vasculature has been 
the subject of lively discussion at this conference inthe past. 
I will defer questions regarding the surgical philosophy at 
Stanford to my colleagues Dr, Mitchell and Dr. Miller, who 
are in the audience. 
The endovascular techniques we have presented allow 
revascularization f compromised peripheral arterial beds 
through relatively noninvasive means. All of our patients 
were referred by our cardiovascular surgical colleagues, 
who considered these patients undesirable surgical candi- 
dates regardless of their age. 
The periprocedure death of 1 (4.5%) of 22 patients 
compares favorably with surgical revascularization tech- 
niques. Revascularization of the mesenteric artery is 
fraught with complications when there has been prolonged 
ischemia regardless of the technique. As you previously 
reported at this meeting, 7 (88%) of 8 patients urgically 
treated for dissection-related mesenteric schemia died as a 
result of this complication. Endovascular management of
dissection-related mesenteric arterial compromise com- 
pares favorably, with seven of eight patients treated for 
mesenteric schemia currently alive. 
The complex ischemic omplications of aortic dissec- 
tion present challenging problems in patients who are poor 
surgical candidates. Endovascular techniques can provide a 
less invasive treatment alternative and would not preclude 
conventional surgical treatment, if necessary. 
Dr. R. Scott Mitchell. I think what we are seeing is not 
a real change in our position about central revasculariza- 
tions. But now with our vascular interventionalists and 
with the use of intravascular ultrasonography, I think we 
are more able to accurately identify what the exact 
mechanism is for the ischemic arterial circulation, whether 
it be mesenteric or renal. If a central aortic reconstruction 
has not been already accomplished, then we try to make a 
decision as to whether acentral aortic repair will relieve the 
supposed mechanism of aortic Or arterial occlusion. If it 
will, then we have proceeded with aggressive type B repairs 
and, of course, all type As. 
There are a number of situations that would not appear 
to be significantly benefited by a proximal aortic repair, 
except unless you carried that repair all the way down and 
included visceral mesenteric vessels, which I think we have 
been reluctant to do in the acute situation. And this is the 
patient population that we have tried to address, that Dr. 
Slonim has so nicely described for you, and I think we are 
trying to learn, as much as treat patients, which patients are 
best served by which interventions. 
Dr. D. Craig Miller. We had a lively debate back in 
Toronto in 1987, and I felt at that time that you and your 
vascular surgery colleagues had been sandbagged by your 
cardiologists and cardiac surgery colleagues in that they did 
not refer these patients to you for visceral or renal or lower 
extremity revascularization u til it was far too late and the 
JOURNAL OF VASCULAR SURGERY 
Volume 23, Number 2 Slonim et al. 253 
horse was certainly out of the barn. That has been true in 
our surgical series. And as you mentioned yourself, if you 
have major visceral or renal ischemia, no matter what you 
do, an abdominal procedure or a chest procedure, you are 
going to face mortality rates of 30%, 50%, or 70%. 
Now that brings me to why I think the interventional 
radiologists have been able to help us so much. And indeed 
all of these cases, if I recall correctly, were referred by the 
surgeons. Now, maybe as we get older, we want to do a 
little bit more sleeping on Friday night or Saturday night, 
and it is nice that the radiologists want to tackle these 
things. But in all seriousness, I think it is the speed with 
which they can improve visceral and renal perfusion, not 
necessarily ower extremity perfusion, and that indeed has 
been lifesaving in a large number of cases. 
Dr. Cambria said that the mortality rate, even if it is 2 
of 22-  I have been in England for a couple of days, I did 
not know someone lse had d ied-  is not.too good, but that 
is 9%. I think it is darn good when you consider what our 
historic surgical mortafity rates would have been, whether 
they had been 'treated by a definitive peripheral vascular 
procedure or a central thoracic aortic procedure. 
And finally, with the question of the mesenteric 
revascularization, yes, we still believe this is a front line, 
first-line therapy and mostly because of its rapidity and not 
so much the fact we want to stay in bed on Friday night. 
Thank you. 
Dr. John V. White (Philadelphia, Pa.). Dr. Slonim, I
would like to compliment you on some outstanding work. 
You and the group at Stanford have become xtraordinarily 
skilled in the use of guidewires and stents in a variety of very 
difficult clinical situations. 
I 'd just like to ask a question regarding the part of the 
conclusion that states that this is a safe and effective 
technique, suggesting that we do know short- and long- 
term outcomes. We recognize that for occlusive disease 
stents can be a two-edged sword. Certainly that they can 
provide us acutely with a lumen that radiographically looks 
excellent; however, they can stimulate a process of neoin- 
timal hyperplasia that is difficult o deal with, especially in 
the renal vessels. The neointimal hyperplastic reaction will 
occur beyond the edge of the stent. Before we make 
ultimate conclusions on these techniques, do we know the 
behavior of stents in visceral vessels that have been 
obstructed by dissection, and will stents result with 
significant neointimal hyperplastic responses that for a 
short-term gain will provide us with a long-term problem? 
Dr. Slonhn. Thank you. We have not had the 
opportunity to restudy most of these patients. It has been 
assumed that the intimal response to the presence ofa stent 
would be similar in a dissected artery as in a nondissected 
artery. Given this assumption, we feel we will achieve good 
long-term patency if we can achieve a stent diameter of at 
least 6 mm. Since a dissected vessel often has a larger than 
normal diameter, we have had no problem achieving this 
diameter in all cases. 
Dr. David C. Brewster (Boston, Mass.). I have one 
quick question. I wonder if you could clarify for me 
whether these ndovascular p ocedures were used in any of 
your patients as the only definitive therapy, as opposed to 
an adjunct either before or after central aortic repair? 
Dr. Slonim. The endovascular p ocedure was the only 
definitive therapy in eight patients (one type A and seven 
type B). These patients have had no surgical repair of the 
dissection. 
